Genovate Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	492.41	510.86	528.51	438.76	434.25
Revenue Growth (YoY)	-3.61%	-3.34%	20.46%	1.04%	-8.14%
Cost of Revenue	315.38	318.21	317.6	283.89	284.5
Gross Profit	177.02	192.65	210.92	154.87	149.75
Selling, General & Admin	112.2	109.74	110.31	106.89	95.49
Research & Development	57.91	59.49	73.61	61.88	55.43
Operating Expenses	170.11	169.22	183.91	168.76	150.92
Operating Income	6.92	23.43	27.01	-13.89	-1.17
Interest Expense	-0.68	-0.52	-0.27	-0.28	-0.25
Interest & Investment Income	6.29	6.5	5.02	2.67	1.61
Earnings From Equity Investments	-2.26	-0.96	-3.88	0.29	0.14
Currency Exchange Gain (Loss)	0.24	0.43	0.21	0.44	-0.19
Other Non Operating Income (Expenses)	2.46	1.71	2.29	1.65	3.44
EBT Excluding Unusual Items	12.97	30.59	30.39	-9.12	3.57
Gain (Loss) on Sale of Investments	0.49	0.47	0.45	0.07	-
Other Unusual Items	-	-	-0.01	0.05	-
Pretax Income	13.45	31.06	30.83	-9	3.57
Income Tax Expense	1.77	5.36	1.49	3.32	3.2
Net Income	11.68	25.7	29.33	-12.32	0.37
Net Income to Common	11.68	25.7	29.33	-12.32	0.37
Net Income Growth	-54.54%	-12.39%	-	-	-99.04%
Shares Outstanding (Basic)	114	115	115	113	113
Shares Outstanding (Diluted)	114	115	115	113	113
Shares Change (YoY)	-0.81%	-0.24%	1.49%	-0.03%	-0.14%
EPS (Basic)	0.10	0.22	0.26	-0.11	0.00
EPS (Diluted)	0.10	0.22	0.25	-0.11	0.00
EPS Growth	-54.55%	-13.69%	-	-	-99.15%
Free Cash Flow	-11.94	24.34	56.81	-22.04	-35.22
Free Cash Flow Per Share	-0.10	0.21	0.49	-0.19	-0.31
Dividend Per Share	-	0.100	0.143	0.167	0.333
Dividend Growth	-	-29.97%	-14.29%	-49.98%	-12.94%
Gross Margin	35.95%	37.71%	39.91%	35.30%	34.48%
Operating Margin	1.40%	4.59%	5.11%	-3.17%	-0.27%
Profit Margin	2.37%	5.03%	5.55%	-2.81%	0.09%
Free Cash Flow Margin	-2.42%	4.76%	10.75%	-5.02%	-8.11%
EBITDA	42.03	58.01	60.9	19.94	32.33
EBITDA Margin	8.54%	11.36%	11.52%	4.54%	7.45%
D&A For EBITDA	35.12	34.58	33.9	33.83	33.5
EBIT	6.92	23.43	27.01	-13.89	-1.17
EBIT Margin	1.40%	4.59%	5.11%	-3.17%	-0.27%
Effective Tax Rate	13.17%	17.26%	4.84%	-	89.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.